Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Simulations Plus Inc (NQ: SLP )

47.47 +1.52 (+3.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 84,856
Open 46.26
Bid (Size) 32.84 (2)
Ask (Size) 48.00 (1)
Prev. Close 45.95
Today's Range 45.66 - 47.62
52wk Range 32.58 - 67.59
Shares Outstanding 20,206,550
Dividend Yield 0.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Stocks Under $50 to Buy (and Never Sell)
Although you usually get what you pay for, these best affordable stocks to invest in punch above their weight class. 
Via InvestorPlace
Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
From Simulations Plus, Inc.
Via Business Wire

Performance

YTD
+27.50%
+27.50%
1 Month
+16.18%
+16.18%
3 Month
+22.35%
+22.35%
6 Month
+18.47%
+18.47%
1 Year
-4.12%
-4.12%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
Via Benzinga
Preview: Simulations Plus's Earnings
Via Benzinga
Roblox And 3 Other Stocks Insiders Are Selling
Via Benzinga
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
MIDD+ 2023 Panelists Discuss How to Increase Gender Equity for Women in Science
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Sidoti March Small-Cap Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds
From Simulations Plus, Inc.
Via Business Wire
Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement
From Simulations Plus, Inc.
Via Business Wire
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Constellation Brands, Walgreens, RPM International And Some Other Big Stocks Moving Lower On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Simulations Plus Reports First Quarter Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Earnings Scheduled For January 4, 2023
Via Benzinga
UniFirst, Progress Software And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.